![](/img/cover-not-exists.png)
A phase II study of pembrolizumab and paclitaxel in patients with relapsed or refractory small-cell lung cancer
Kim, Yu-Jung, Keam, Bhumsuk, Ock, Chan-Young, Song, Sanghoon, Kim, Miso, Kim, Se Hyun, Kim, Ki Hwan, Kim, Jin-Soo, Kim, Tae Min, Kim, Dong-Wan, Lee, Jong Seok, Heo, Dae SeogVolume:
136
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/j.lungcan.2019.08.031
Date:
October, 2019
File:
PDF, 2.79 MB
english, 2019